A genetic alteration in RICTOR significantly enhanced the overall survival (OS) of patients with UCEC and CESC, as illustrated in Figure 3C. Conversely, ACC patients with RICTOR genetic alteration exhibited a significantly poor prognosis in terms of OS (Figure 3C). This evidence concerns the gene RICTOR and adrenal cortex carcinoma.